Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 901-905

  Klaassen, Corné H W ^a   de Valk, Hanneke A ^a   Curfs Breuker, Ilse M ^a   Meis, Jacques F ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

14 sterol demethylase; L98H; Promoter; Susceptibility

Indexed keywords

DOUBLE STRANDED DNA; FLUORESCENT DYE; TRIAZOLE DERIVATIVE; ANTIFUNGAL AGENT; PRIMER DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DNA POLYMORPHISM; FUNGUS ISOLATION; MUTATIONAL ANALYSIS; NETHERLANDS; NONHUMAN; PHENOTYPE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; ASPERGILLOSIS; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NETHERLANDS; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; TRIAZOLES;

EID: 77953721389     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq041     Document Type: Article

References (11)

1. Mellado E, Garcia-Effron G, Buitrago MJ et al. Targeted gene disruption of the 14-α sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536-8.
2. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M et al. Apointmutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2003; 47: 1120-4.
3. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 2004; 48: 2747-50.
4. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897-904.
5. da Silva Ferreira ME, Capellaro JL, dos Reis Marques E et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother 2004; 48: 4405-13.
6. Chen J, Li H, Li R et al. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 2005; 55: 31-7.
7. Howard SJ, Webster I, Moore CB et al. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28: 450-3.
8. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi-Second Edition: Approved Standard M38-A2. CLSI, Wayne, PA, USA, 2008.
9. Trama JP, Mordechai E, Adelson ME. Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing. J Clin Microbiol 2005; 43: 906-8.
10. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerging Infect Dis 2009; 15: 1068-76.
11. Verweij PE, Snelders E, Kema GH et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 2009; 9: 789-95.